Cancer Trials Ireland

Cancer Trials Ireland Cancer Trials Ireland is a not for profit Clinical Research Organisation.

Our vision is for patients with cancer to have the opportunity to participate in potentially life enhancing cancer trials in Ireland.

Our Let's Talk Trials webinar is now available to watch back on our website.A heartfelt thank you to Anne Bodley for sha...
03/06/2026

Our Let's Talk Trials webinar is now available to watch back on our website.

A heartfelt thank you to Anne Bodley for sharing her personal experience of taking part in a cancer clinical trial. Hearing directly from patients is so important in helping others better understand cancer research and the role trials play in improving cancer care.

Watch the recording here: https://bit.ly/4dGwZ8s

A fantastic recruitment milestone for the RAMP-301 study in Ireland.The team at St James's Hospital Dublin  led by Prof ...
02/06/2026

A fantastic recruitment milestone for the RAMP-301 study in Ireland.

The team at St James's Hospital Dublin led by Prof Karen Cadoo, has exceeded its recruitment target for this Phase 3 study in recurrent low-grade serous ovarian cancer, with four patients now enrolled against a target of three.

This is a significant achievement in a rare cancer setting, and reflects the commitment of the SJH team, as well as the strength of collaboration across Irish sites.

Referral pathways between sites have played an important role in identifying and referring eligible patients, helping more patients in Ireland access this important international cancer trial.

Enrolment remains open for the moderate hepatic impairment (MHI cohort) cohort. This cohort invites patients with recurrent LGSOC who have progressed on a prior platinum-based therapy and have moderate hepatic impairment: https://bit.ly/3Rmhmuv

Congratulations to everyone involved.

We’re very pleased to see Cancer Trials Ireland recognised with finalist places in two categories at the 2026 The Life S...
28/05/2026

We’re very pleased to see Cancer Trials Ireland recognised with finalist places in two categories at the 2026 The Life Science Awards

Cancer Trials Ireland has been shortlisted for the Operational Excellence Award, while our Start-Up Team has been named a finalist in the Life Sciences Team of the Year category.

These nominations recognise the significant work undertaken to improve the speed, consistency and efficiency of cancer clinical trial start-up in Ireland, helping support faster access to trials for patients.
Best of luck to all finalists ahead of tonight’s awards

We are so grateful to Séamus Conaty for sharing his story so openly during Brain Cancer Awareness Month.Séamus was diagn...
28/05/2026

We are so grateful to Séamus Conaty for sharing his story so openly during Brain Cancer Awareness Month.

Séamus was diagnosed with a high-grade astrocytoma after experiencing worsening headaches, nausea, vomiting and numbness down his left side. His story is a powerful reminder of how suddenly life can change, and why awareness matters.

We are very fortunate that Séamus is now part of Cancer Trials Ireland’s Patient Consultants Committee, where he brings his lived experience and perspective to our work. He is also a member of our Central Nervous System Disease-Specific Sub-Group, helping to ensure that patient voices are part of how cancer trials are developed, understood and communicated.

Patient partnership is at the heart of what we do. It helps us make sure that our work reflects the needs, concerns and experiences of people affected by cancer.

Thank you to Séamus for sharing his story, and to the Irish Cancer Society for helping bring it to a wider audience.

You can read Séamus’s full story below.

Séamus Conaty, 36, who lives in Dublin and is originally from Monaghan, started getting headaches in the summer of 2023. He initially put this down to being a new parent, as his son was born that June, and he was also working in a stressful job.

“On the August bank holiday, I had the first headache that was so bad it actually stopped me in my tracks,” says Séamus, who is sharing his story to mark Brain Cancer Awareness Month.

“I’d gone to my GP about it, who initially thought my symptoms were most likely linked to my heart, as I was also experiencing low blood pressure and dizzy spells when I stood up.”

However, on Christmas Day 2023, before he received the results of tests on his heart, things took a turn. Séamus woke up earlier than usual as he felt unwell. This worsened throughout the day, and later lead to a diagnosis that he never expected.

“That morning I had a headache that kept getting worse, and this was quickly followed by nausea, vomiting and a numbness down my left side.”

A brain MRI later that day identified a tumour in the right frontal lobe and that night he was on the operating table in Beaumont Hospital, to undergo an emergency brain surgery.

“In the waiting room the surgeon’s registrar told my wife and my parents that they had three aims for the surgery. The first was to remove as much of the tumour as possible, the second was to preserve as much of my functioning as possible, and the third and most critical aim, was to save my life. It really drove home the severity of the situation and what was at stake.”

After the surgery, Séamus was placed in an induced coma for over 24 hours. Several days later, he received his full diagnosis, a high-grade astrocytoma.

Read Seamus's full story: https://brnw.ch/21x2RY9

Looking back on a fantastic   in Stockholm.Cancer Trials Ireland had a busy few days, with strong representation across ...
28/05/2026

Looking back on a fantastic in Stockholm.

Cancer Trials Ireland had a busy few days, with strong representation across meetings, presentations and discussions focused on advancing radiation oncology research.

A highlight was seeing Dr Darragh Browne present quality-of-life results from the CTRIAL-IE 09-06 Endometrial IMRT study, led by Chief Investigator Prof Charles Gillham.

Great to connect with colleagues and collaborators, including TOURIST lung platform Chief Investigator Dr David Woolf, alongside Prof Gerry Hanna and Dr Ronan McDermott.

We also attended IRROG presentations and meetings on new study proposals, as well as an interesting debate involving FAST Forward Boost, which is expected to open at Irish sites this summer.

It was brilliant to catch up with Bridget Carr, ovarian cancer advocate and member of the Cancer Trials Ireland Patient ...
27/05/2026

It was brilliant to catch up with Bridget Carr, ovarian cancer advocate and member of the Cancer Trials Ireland Patient Consultants Committee, and Prof Sharon O’Toole at the All-Island Cancer Summit last week.

Pictured with us is the BEAT Bench, a powerful awareness installation created for World Ovarian Cancer Day to spark conversations about ovarian cancer symptoms and the importance of acting on persistent changes.

Bridget recently shared her own story with the media in a powerful article about diagnosis, treatment, recovery and why she continues to advocate for others.

Read Bridget’s story here: https://bit.ly/4tWK9TX

Irish Network of Gynaecological Oncology

More sites. More collaboration. More patients accessing international cancer trials in Ireland. 👏The EORTC-sponsored DE-...
26/05/2026

More sites. More collaboration. More patients accessing international cancer trials in Ireland. 👏

The EORTC-sponsored DE-ESCALATE study continues to build momentum, with 8 of 10 participating Cancer Trials Ireland sites now activated and open to enrolment.

Thanks to the incredible work of investigators, research nurses and trial teams across the network, 12 patients have now been recruited in Ireland to date, with Tallaght University Hospital currently leading enrolment.

Every activation, referral and recruitment reflects a huge team effort across sites in Ireland working together to expand access to international cancer trials.

Read more: https://bit.ly/4fiLznW

XPORT-EC-02 has officially closed to recruitment globally, with 257 patients enrolled worldwide.A huge thank you to all ...
25/05/2026

XPORT-EC-02 has officially closed to recruitment globally, with 257 patients enrolled worldwide.

A huge thank you to all investigators, research teams and participating sites involved in Ireland. While 3 patients were ultimately enrolled across Irish sites, the work behind this study extended far beyond enrolment numbers, with 11 patients formally screened and many more patients assessed for potential eligibility across sites in Ireland.

This complex international endometrial cancer study required significant collaboration, coordination and commitment from teams across the country, including colleagues who supported referrals and pre-screening activity outside of officially activated sites.

Thank you to everyone involved in supporting this important study and contributing to international research collaboration.

Our Public Webinar on Cancer Trials is underway! Head to our website to view. Find the link in our bio 🔗
22/05/2026

Our Public Webinar on Cancer Trials is underway! Head to our website to view. Find the link in our bio 🔗

Different perspectives. Different lived experiences. Different priorities - all shaping the discussion at Cancer Retreat...
22/05/2026

Different perspectives. Different lived experiences. Different priorities - all shaping the discussion at Cancer Retreat 2026.

Our Public & Patient Involvement panel explored how patient involvement in cancer trials in Ireland has evolved over the last decade, how the Cancer Trials Ireland Patient Consultants Committee has grown alongside the organisation, and why barriers to involvement in both advocacy and trials themselves still need to be addressed.

A hugely thoughtful and important conversation from Patrick Kivlehan and Martin Sweeney from our PCC, Niki Warner from the Irish Cancer Society, and Emer Mulvaney, PPI Programme Manager at Cancer Trials Ireland.

Address

RCSI House, 121 Street Stephen's Green
Dublin

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+35316677211

Alerts

Be the first to know and let us send you an email when Cancer Trials Ireland posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share